The value of extended amygdala structures in emotive effects of narcogenic with diverse chemical structure by Roik, R. O. et al.
The value of extended amygdala structures in emotive 
effects of narcogenic with diverse chemical structure
Roman O. Roik1, Andrei A. Lebedev1, Petr D. Shabanov1
1 Institute of Experimental Medicine, 12 Academician Pavlov St., St.-Petersburg 197376 Russia
Corresponding author: Petr D. Shabanov (pdshabanov@mail.ru)
Academic editor: Oleg Gudyrev  ♦  Received 20 July 2019  ♦  Accepted 26 August 2019  ♦  Published 30 September 2019
Citation: Roik RO, Lebedev AA, Shabanov PD (2019) The value of extended amygdala structures in emotive effects of narcogenic 
with diverse chemical structure. Research Results in Pharmacology 5(3): 11–19. https://doi.org/10.3897/rrpharmacology.5.38389
Abstract
Introduction: Studies on the mechanisms of the reinforcing action of opioid and non-opioid narcotics confirmed the 
existence in the brain of a specialized system named the extended amygdala.
Materials and methods: To clarify the value of the extended amygdala structures (bed nucleus, central nucleus of the 
amygdala and nucleus accumbens shell) in the mechanisms of unconditioned and conditioned reinforcement activated by 
various narcogenic, this paper carried out a neuropharmacological analysis of these effects, using blockade of dopamine 
receptors, GABA, opioids and CRF receptors within these brain structures, as well as an analysis of behavioral responses 
by self-stimulation (unconditioned reinforcement) and conditioned place preference (CPP) (conditioned reinforcement).
Results and discussion: The central amygdala and the bed nucleus have a controlling influence on the hypothalamus, 
which is predominantly of CRF-, GABA- and dopaminergic nature. Through D1 dopamine receptors,, a direct positive 
(activating) effect on the lateral hypothalamus is made. The D2 receptor blockade of the nucleus accumbens prevents 
narcogenic from exerting the reinforcing properties, which are primarily stimulating. The blockade of the D1 recep-
tors of the nucleus accumbens by SCH-23390 prevents the expression of unconditioned and conditioned reinforcing 
properties of predominantly opiates and opioids. The blockade of GABAA receptors in the nucleus accumbens with 
bicuculline prevents the manifestation of the primary and secondary reinforcing properties (CPP) of psychostimulant 
drugs (amphetamine), without affecting the effects of opiates and opioids (fentanyl and leu-enkephalin).
Conclusion: The pharmacological analysis proves that CRF, dopamine and GABA receptors are most important for the 
correction of reinforcement activated by various narcogenic.
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Introduction
The evolution of views on the mechanisms of the reinfor-
cing action of opioid and non-opioid narcotics confirmed 
the existence in the brain of a specialized system of emo-
tiogenic structures, first of all, structures of the extended 
amygdala. It includes the bed nucleus of the stria termi-
nalis (BNST), the central nucleus of the amygdala (CeA), 
the medial part (shell) of the nucleus accumbens (NA) 
and the substantia innominata receiving the innervation 
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from the dopaminergic neurons of the ventral forebrain 
bundle (Koob 2009a, Koob 2009b, Shabanov and Lebe-
dev 2008). It is the structures of the extended amygda-
la complex, originally identified on the basis of their 
neuroanatomical similarity (Alheid and Heimer 1996) 
that make up the main structural and functional system 
for delivering emotional and motivational effects of va-
rious narcogenic mediating their action on effector organs 
(Giardino et al. 2018, Shabanov and Lebedev 2008).
In order to clarify the value of the extended amygda-
la structures (the bed nucleus, the central nucleus of the 
amygdala and the nucleus accumbens shell) in the mech-
anisms of unconditioned and conditioned reinforcement 
activated by various narcogenic (psychotropic substanc-
es), a neuropharmacological analysis of these effects was 
carried out in this paper, using blockade of dopamine, 
GABA, opioids and CRF receptors within these brain 
structures, and an analysis of behavioral responses by 
self-stimulation (unconditioned reinforcement) and con-
ditioned place preference (conditioned reinforcement). 
Thus, a number of fundamental questions of the exper-
imental and clinical pharmacology of narcogenic were 
addresses to, namely: 1) to find out the value of the struc-
tures of the extended amygdala complex in the emotive 
effects of the narcogenic (psychotropic drugs) of various 
chemical structures; 2) to analyze the mechanisms of con-
jugation of unconditioned and conditioned reinforcing 
properties of narcogenic during emotive reactions, and 
finally, 3) to identify the main targets for influencing the 
reinforcing mechanisms of the brain in order to reduce 




The experiments were performed on 869 Wistar males 
rats weighing 200–220 g, contained in a group of 5 in-
dividuals (before the implantation of electrodes into the 
brain) in standard plastic boxes in vivarium conditions of 
the Neuropharmacology Department of the Institute of 
Experimental Medicine. The air temperature was main-
tained within 20–22 °C, relative humidity – 50–70%. The 
animals were kept with free access to water and food in 
the inverted light conditions of 8.00–20.00. All the expe-
riments were conducted in the autumn-winter period. The 
study was approved by the local ethical committee of the 
Institute of Experimental Medicine.
Implantation of electrodes and cannulas into brain 
structures
Implantation of electrodes and cannulas into the brain of 
rats was performed under Nembutal anesthesia (50 mg/
kg), using a stereotactic apparatus manufactured by Me-
dicor, Hungary. Nickel-chromium monopolar electrodes 
in glass insulation (electrode diameter 0.25 mm, length 
of the exposed tip 0.25–0.30 mm, its thickness 0.12 mm) 
were implanted bilaterally into the lateral hypothalamic 
nucleus according to the following coordinates: AP = 2.5 
mm posterior to bregma, SD = 2.0 mm lateral to sagittal 
suture, H = 8.4 mm below the skull surface (König and 
Klippel 1963). An indifferent nickel-chromium electrode 
was attached to the skull of an animal. All electrodes were 
termintaed in a micro-connector, which was fixed on the 
skull with self-hardening plastic.
Metal guide cannulas made of stainless steel with a 
diameter of 0.2 mm were implanted unipolarly into the 
right central nucleus of the amygdala according to the fol-
lowing coordinates: AP = 2.8 mm posterior to bregma, 
SD = 3.9 mm lateral to sagittal suture, H = 8.2 mm be-
low the skull surface, or into the right bed nucleus of the 
stria terminalis according to the coordinates: AP = 0.5 mm 
posterior to bregma, SD = 1.5 mm lateral to the sagittal 
suture, H = 6.7 mm below the skull surface (Fig. 1), or 
into the right nucleus accumbens shell (Fig. 2): AP = 2.2 
anterior to bregma, SD = 1.2 mm lateral to sagittal suture, 
H = 6.5 mm below the skull surface, according to the atlas 
by K.P.König and A.A.Klippel (1963). The cannulas were 
fixed on the skull of the animal with self-hardening plas-
tic, and, after the operation, were closed with a special 
obturator, which was temporarily removed to introduce 
substances into the brain structure. With the intrastructur-
al introduction of substances, metal micro-cannulas (di-
ameter 100 μm), the tips of which were 0.2 mm longer 
than the guides, were inserted into the guides.
Behavioral experiments were not started until 10 days 
after surgery. At the end of all behavioral experiments, the 
morphological control of the localization of the tips of the 
electrodes was performed on a series of frontal sections 
of the brain, which were stained according to the Nissl 
method and previously coagulated through implanted 
electrodes with a current of 1 mA for 30 s.
Methods of self-stimulation of the brain in rats
To reproduce the brain self-stimulation in rats, the clas-
sic version of brain self-stimulation in the form of pedal 
self-stimulation in the Skinner’s box was used. The trai-
ning procedure for rats to press the pedal in the Skinner’s 
box to produce electrical stimulation of the brain (rectan-
gular pulses of negative polarity, 1 ms duration, 100 Hz 
frequency, for 0.4 s, current threshold values in the “fixed 
ratio” mode – FR1) started no earlier than 10 days after 
the implantation of electrodes into the brain.
To repeat stimulation, an animal was forced to re-press 
the pedal. The frequency, time of each pedal pressing and 
the thresholds of self-stimulation reactions were analyzed. 
Pharmacological agents were injected on the 3rd day of the 
experiment, after the stabilization of the reaction using a 
fixed value of current. The number of pedal pressings was 
recorded for 10 minutes of the experiment, and the “mis-
match” coefficient was calculated; then the intrastructural 
micro-injection of the drug was made, and, 15–20 minutes 
Research Results in Pharmacology 5(3): 11–19 13
later, both the number of pedal pressings and the “mis-
match” coefficient were recorded over a 10-minute interval 
(Shabanov and Lebedev 2013). The “mismatch” coefficient 
ranges from -1 to +1 and shows a share of activation of the 
positive and negative reinforcing phase of self-stimulation.
Conditioned place preference
The conditioned place preference (CPP) was produced 
in a 60×30×30 cm apparatus consisting of two square 
chambers (compartments) of the same size, connected by 
a 10×10 cm door. The inner surface of one compartment 
was painted white and the other – dark. The texture of the 
floor was different: in one chamber it was a fine grate, in 
the other – a smooth dark brown floor. The acquisition of 
CPP was carried out for 8 days (Rosas et al. 2017). On 
the 1st day, the rat was placed for 10 minutes in the appa-
ratus with the door open to familiarize and determine the 
initial preference of one of the apparatus compartments. 
Starting from the 2nd day of the experiment, each rat was 
injected with either one of the pharmacological prepara-
tions (on the 2nd, 4th and 6th days), or saline (on the 3rd, 5th 
and 7th days) and immediately placed for 60 minutes in 
the apparatus: in the non-preferable compartment in case 
of the administration of narcogenic and in the preferable 
compartment in case of the injection of saline. The door 
between the compartments of the apparatus in this case 
was closed. On the 8th day of the experiment, the door was 
opened, and the animal was placed for 10 minutes in the 
non-preferable compartment without the administration 
of the drug. Time spent in each of the compartments, as 
well as the number of shuttles between the compartments. 
An increase in time spent in the originally non-preferable 
compartment of the chamber was interpreted as a conditi-
oned place preference (the main criterion is a 50% incre-
ase in the time spent in the non-preferable compartment 
of the total exposure). An additional criterion of preferen-
ce was a general increase in the number of shuttles bet-
ween the compartments.
Pharmacological substances used for analysis
For pharmacological analysis, a psychomotor stimulant 
amphetamine (β-phenylisopropylamine hydrochloride; 
A B
Figure 1. Morphological picture of zones of microinjection of substances into the central nucleus of the amygdala (A) and the bed 
nucleus of the stria terminalis (B) The coordinates are according to the atlas by K.P. König and A.A. Klippel (1963). Frontal sections 
are shown in mm relative to bregma.
Figure 2. Projections (locations) of injections of pharmacolog-
ical agents into the nucleus accumbens shell 2.2 mm anterior 
to bregma of the rat’s skull (indicated by dark circles). Note: 
AcbS – n. accumbens shell, AcbC – n. accumbens core, CPu –n. 
caudatum and putamen.
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Sigma, USA; 1 mg/kg), synthetic opiate analgesic fenta-
nyl citrate (Vector, Russia; 0.1 mg/kg), barbiturate pen-
tobarbital sodium (ethaminal sodium; Vector, Russia; 5 
mg/kg), opioid leu-enkephalin (H-Tyr-Gly-Gly-Phe-Leu-
OH; Sigma, USA; 1 mg/kg), an opioid receptor antago-
nist naloxone (Narcanti; Du Pont de Nemur, Germany; 
1 mg/kg) were administered intraperitoneally 30 minutes 
before the study of self-stimulation (after determining its 
background values). Bicuculline (Sigma, USA), a GA-
BAA receptor antagonist, lidocaine (Egis, Hungary), an 
influx Na+ channel blocker (local anesthetic), SCH-23390 
(halobenzazepine; Sigma, USA), a D1 dopamine receptor 
antagonist, sulpiride (Sanofi-Aventis France, France), a 
D2 dopamine receptor antagonist, and astressin (DS La-
boratories, USA), a non-selective CRF antagonist; all at a 
dose of 1 μg were injected intrastructurally into one of the 
structures of the extended amygdala (n. accumbens shell, 
central nucleus of amygdala, bed nucleus of the stria 
terminalis) through a cannula implanted into the brain 
structure (Shabanov and Lebedev 2013). The substances 
(1 μg per injection) were dissolved in distilled water and 
injected in a volume of 1 μl using a CMA-100 microinjec-
tor (Sweden) for 30 s 15–20 min before the testing after 
determining the initial (background) values of the lateral 
hypothalamus self-stimulation. Considering the chronic 
nature of the experiment (it lasted on average 30–40 days 
for each rat), the pharmacological agents were re-admi-
nistered to each animal via cannula with an interval of at 
least 5 days between injections so that one operated rat 
received the same pharmacological substance 3–4 times. 
Each time before the administration of the substance, the 
background values of the self-stimulation reaction were 
determined, which were qualified as the control values for 
this experiment. Overall, the total number of the expe-
riments (10–12 for each substance), rather than just the 
number of animals studied, was taken into account. This 
principle of substance injection is common for this kind 
of studies (Koob 2017, Shabanov and Lebedev 2013).
Results and discussion
Involvement of the nucleus accumbens shell in the re-
inforcement
A study of the involvement of the nucleus accumbens 
shell in the realization of the reinforcing effects of psy-
cho-stimulant (amphetamine) and hypno-sedative (pento-
barbital, fentanyl citrate and leu-enkephalin) narcogenic 
in rats in models of unconditioned (self-stimulation of 
the brain) and conditioned (acquisition and expression of 
CPP) reinforcement showed that intrastructural adminis-
tration of blockers, as a rule, leads to a decrease in the 
reinforcing effect of narcogenic (Table 1).
An exception was the enhancement of the reinforc-
ing properties of leu-enkephalin by lidocaine in the test 
of acquisition and expression of CPP, of bicuculline and 
SCH-23390 on the acquisition and expression of CPP 
by fentanyl citrate and pentobarbital and astressin on 
self-stimulation of the brain, stimulated by leu-enkepha-
lin. That is, opiates (fentanyl citrate) and opioids (leu-en-
kephalin) responded most often by enhancing the rein-
forcing properties after intrastructural administration of 
pharmacological blockers.
In all other cases, intra-accumbental administration 
of the studied pharmacological agents, as a rule, led to a 
decrease in the reinforcing properties of the narcogenic. 
At the same time, in almost all combinations, the used 
pharmacological blockers reduced the unconditioned and 
conditioned reinforcing properties of a psycho-stimulant 
amphetamine. This, of course, is of practical interest from 
the point of view of the biological prevention of abusing 
psycho-active substances of the amphetamine type. On the 
other hand, the activation of the reinforcing properties of 
the brain by pentobarbital was often resistant to the ac-
tion of dopamine receptor antagonists (sulpiride and SCH-
23390), which emphasized the inexpediency of using neu-
roleptics to treat behavioral dependence on barbiturates.
Overall, a sufficiently high anti-narcogenic activity 
of the used pharmacological blockers was demonstrated 
when they were intrastructurally administered into the 
n. accumbens shell, which should be taken into account 
when developing issues of biological prevention of de-
pendence on psychotropic drugs.
Involvement of the central nucleus of the amygdala in 
reinforcement
The studies showed that the central nucleus of the 
amygdala plays an important role in the realization of 
the unconditioned and conditioned reinforcing effects of 
the psycho-stimulant (amphetamine) and hypno-sedative 
(pentobarbital, fentanyl citrate and leu-enkephalin) narco-
genic in rats. The first issue which was faced in the expe-
riment was the neurohormonal component of the central 
nucleus of the amygdala. The injection of astressin into 
it, a non-selective antagonist of corticoliberin receptors 
(CRF), inhibited the self-stimulation of the lateral hypot-
halamus by 55%. This emphasizes the importance of the 
central amygdala nucleus as a stres-inducing source of 
reinforcement regulation.
After intra-amygdalar administration of the CRF an-
tagonist, all the studied narcogenic, with the exception 
of leu-enkephalin, showed high reinforcing properties. 
Moreover, against the background of other receptor 
blockers (lidocaine, SCH-23390, sulpiride), narcogens, as 
a rule, activated the reaction of the lateral hypothalamus 
self-stimulation. Quite different patterns emerged in the 
study of the acquisition and expression of CPP in rats, 
when no psycho-activating effect of narcogenic drugs was 
observed, with rare exceptions (bicuculline moderately 
increased the expression of CPP of fentanyl citrate, and 
naloxone – the expression of CPP of pentobarbital). In all 
other cases, the effects of pharmacological blockers, as a 
rule, led to a decrease in the acquisition and expression of 
CPP of all the studied narcogenic. There was also another 
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exception: the reinforcing properties of pentobarbital re-
mained unchanged towards the acquisition of CPP after 
administration of most pharmacological blockers in the 
central nucleus of the amygdala (lidocaine, SCH-23390, 
sulpiride, naloxone). At the same time, antagonists of do-
pamine receptors (SCH-23390 and sulpiride) and nalox-
one showed maximum activity suppressing the reinforc-
ing properties (Table 2).
Thus, when comparing the effects of pharmacological 
blockers of different receptors (GABAA, D1, D2 of dopa-
mine, opioids, CRF) and influx sodium ion channels acting 
at different points of application or targets (the n. accum-
bens shell and the central nucleus of the amygdala), they 
significantly differ. The n. accumbens shell, regarded as 
the target of exposure to pharmacological agents, behaves 
predictably, providing in most cases negative responses to 
unconditioned and conditioned reinforcing stimuli.
The central nucleus of the amygdala appears to be a 
convergence point of both reinforcing signals and non-spe-
cific stress-inducing inputs, due to which the response to 
reinforcement is determined not only by the expected pos-
itive effect of the narcogen, but also by the non-specific 
motivational component related to a stress response.
Involvement of the bed nucleus of the stria terminalis 
in the reinforcement
Summarizing the results, it is important to emphasize that 
the bed nucleus, related to the structures of the extended 
amygdala, is directly involed in the formation and reali-
Table 1. Comparison of the effects of pharmacological blockers administered into the nucleus accumbens shell on unconditioned 
and conditioned reinforcing properties of psycho-stimulant and hypno-sedative narcogenic in rats.
Drugs Amphetamine Fentanyl citrate Pentobarbital Leu-enkephalin
Self-stimulation of the lateral hypothalamus
Bicuculline - 0 -- 0
Lidocaine - -- - +
SCH-23390 - -- 0 0
Sulpiride -- 0 0 +
Astressin 0 -- 0 -
Acquisition of CPP
Bicuculline -- - - +
Lidocaine - - - -
SCH-23390 - - + --
Sulpiride -- - - 0
Naloxone - -- - --
Expression of CPP
Bicuculline -- + - 0
Lidocaine -- - - ++
SCH-23390 - + - --
Sulpiride -- - 0 -
Naloxone -- -- + -
Note: “0” – no effect; “+” – a weak activating effect; “++” – a moderate activating effect; “+++” – a strong activating effect; “-” – a weak inhibitory 
effect; “--” – a moderate inhibitory effect.
Table 2. Comparison of the effects of pharmacological blockers administered into the amygdala on unconditioned and conditioned 
reinforcing properties of psycho-stimulant and hypno-sedative narcogenic in rats.
Drugs Amphetamine Fentanyl citrate Pentobarbital Leu-enkephalin
Self-stimulation of the lateral hypothalamus
Astressin +++ + ++ --
Lidocaine ++ 0 + +
SCH-23390 0 + + +
Sulpiride + 0 + +
Acquisition of CPP
Bicuculline - - -- 0
Lidocaine - -- 0 -
SCH-23390 - - 0 --
Sulpiride -- - 0 0
Naloxone - -- 0 --
Expression of CPP
Bicuculline -- + - 0
Lidocaine - -- - -
SCH-23390 -- --- -- ---
Sulpiride -- - 0 -
Naloxone - -- + +
Note: “0” – no effect; “+”– a weak activating effect; “++”– a moderate activating effect; “+++” – a strong activating effect; “-” – a weak inhibitory 
effect; “--” – a moderate inhibitory effect; “---” – a strong inhibitory effect.
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zation of the unconditioned and conditioned reinforcing 
properties of the psycho-stimulant and hypno-sedative 
(pentobarbital, fentanyl citrate and leu-enkephalin) nar-
cogenic in rats (Table 3).
The pharmacological analysis made by using receptor 
blocking agents (GABAA, D1, D2 dopamine, opioids) or 
influx sodium ions antagonist (lidocaine) showed that the 
reinforcing effects of amphetamine were the most labile in 
the models of self-stimulation of the lateral hypothalamus 
and conditioned place preference (acquisition and expres-
sion of CPP), which decreased under the influence of all 
the investigated substances. The effects of synthetic opi-
oid fentanyl citrate may be enhanced under the influence 
of intra-structurally administered bicuculline or lidocaine, 
if using the techniques to study conditioned reinforcement 
(CPP, both options of acquisition and expression), and, on 
the contrary, may be suppressed in unconditioned rein-
forcement methods (self-stimulation). Similar, but more 
variable responses, were obtained for leu-enkephalin.
The most problematic results relate to pentobarbital, 
the reinforcing effects of which can both be enhanced (by 
bicuculline in the self-stimulation of the brain and CPP) 
and suppressed (primarily by SCH-23390). This indicates 
a lack of knowledge of D1 dopamine receptors in the im-
plementation of the reinforcing properties of narcogenic 
and emphasizes the prospect of their possible use as an-
ti-narcotic drugs. The use of D2 dopamine receptor antag-
onists (typical and atypical neuroleptics) for this purpose 
is not always effective.
The present work aimed to clarify the significance of 
the CRF, GABA, dopamine and opioids systems in the 
main structures of the extended amygdala (the bed nu-
cleus of the stria terminalis, the central nucleus of the 
amygdala and the nucleus accumbens shell) for the re-
inforcing effects of a number of psycho-active substanc-
es (opiates, opioids, psycho-stimulants, barbiturates) on 
the self-stimulation of the lateral hypothalamus, as well 
as the acquisition and expression of the conditional place 
preference (CPP) in rats. Intrastructural administration 
of various blockers of receptors localized in these brain 
structures was selected as the main methodological re-
search tool, with an assessment of the implementation of 
the self-stimulation of the lateral hypothalamus as an indi-
cator of unconditioned reinforcement, and CPP as condi-
tioned reinforcement (Schreiber et al. 2019, Waraczynski 
et al. 2015). That is, the similarities and differences in the 
mechanisms of unconditioned and conditioned reinforce-
ment were compared in various behavioral models that 
are most common for studying the described phenomena.
It was proved by the methods of the pharmacological 
analysis that the unconditioned and conditioned reinforc-
ing effects of different narcogenic (psycho-stimulants, 
opiates, hypno-sedatives, and opioid neuropeptides) have 
their own characteristics of involving the emotive and 
mnestic components of the general integrative reinforce-
ment mechanism and are mediated mainly by dopamin-
ergic mechanisms of the mesocorticolimbic system and 
central mechanisms of stress associated with the participa-
tion of receptors for CRF, dopamine, GABA and opioids 
(Shabanov and Lebedev 2013). At the same time, blockade 
of CRF, dopamine, GABA and opioid receptors, as well 
as influx ionic Na+ currents in the neurons of the central 
nucleus of the amygdala, the bed nucleus and the nucleus 
accumbens shell, eliminates or significantly reduces the re-
inforcing effects of narcogenic (amphetamine, fentanyl cit-
rate, pentobarbital and leu-enkephalin). These neurochem-
ical structures of the extended amygdala appear to be vital 
for influencing the reinforcement mechanisms (Klein et al. 
2017). In particular, the central nucleus of the amygdala 
and the bed nucleus have a controlling influence on the 
hypothalamus, which is predominantly of CRF-, GABA- 
and dopaminergic nature (Pina and Cunningham 2017). 
Through D1 dopamine receptors, a direct positive (activat-
ing) effect on the lateral hypothalamus is realized. The D2 
Table 3. Comparison of the effects of pharmacological blockers administered into the bed nucleus of stria terminalis on uncondi-
tioned and conditioned reinforcing properties of psycho-stimulant and hypno-sedative narcogens in rats.
Drugs Amphetamine Fentanyl citrate Pentobarbital Leu-enkephalin
Self-stimulation of the lateral hypothalamus
Bicuculline - - + 0
Lidocaine - - 0 -
SCH-23390 -- -- -- ---
Sulpiride -- --- 0 -
Naloxone - -- + --
Acquisition of CPP
Bicuculline -- ++ +++ ++
Lidocaine - ++ - +++
SCH-23390 -- --- -- ---
Sulpiride -- -- 0 -
Naloxone -- --- - --
Expression of CPP
Bicuculline -- ++ +++ ++
Lidocaine - ++ - +++
SCH-23390 -- --- --- ---
Sulpiride -- -- 0 -
Naloxone -- -- - --
Note: “0” – no effect; “+”– a weak activating effect; “++”– a moderate activating effect; “+++” – a strong activating effect; “-” – a weak inhibitory 
effect; “--” – a moderate inhibitory effect; “---” – a strong inhibitory effect.
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receptor blockade of the nucleus accumbens shell prevents 
the realization of the reinforcing properties (self-stimu-
lation of the brain, CPP) of psychostimulant narcogenic 
drugs (Shabanov and Lebedev 2013). At the same time, 
the blockade of D1 receptors of the nucleus accumbens 
shell by SCH-23390 prevents the acquisition of uncondi-
tioned and conditioned reinforcing properties of predomi-
nantly opiates and opioids. The blockade of the nucleus ac-
cumbens shell GABAA receptors with bicuculline prevents 
the manifestation of the primary and secondary reinforcing 
properties (CPP) of the psycho-stimulant narcogens (am-
phetamine), without influencing the effects of opiates and 
opioids (fentanyl citrate and leu-enkephalin).
Thus, using the pharmacological analysis, it was 
demonstrated that receptors of CRF, dopamine and GABA 
are the most important for the correction of reinforcement 
activated by various narcogenic (psycho-stimulants, opi-
ate drugs, hypno-sedatives and opioid neuropeptides); 
therefore, they should be considered as promising targets 
for influencing the reinforcing mechanisms of the brain 
in order to reduce the narcotic effect of the studied psy-
chotropic drugs. The data obtained open up the prospect 
of searching for agents with antagonistic activity against 
CRF, dopamine, GABA and opioid receptors to correct 
various forms of drug addiction.
Conclusions
1. The neuropharmacological analysis of the cen-
tral mechanisms of unconditioned and condi-
tioned reinforcing properties of chemically di-
verse narcogenic drugs revealed their functional 
contingency in the implementation of emotional 
reactions, provided both by individual structures 
of the extended amygdala (central nucleus of the 
amygdala, bed nucleus of the stria terminalis, 
nucleus accumbens shell) and specialized neu-
rochemical systems (CRF, dopamine, GABA), 
considered as targets for influencing the reinforc-
ing brain mechanism in order to reduce the nar-
cotic effect of the studied psychotropic drugs of 
opioid and non-opioid types.
2. The blockade of CRF, dopamine, and GABA recep-
tors, as well as influx Na+ ion currents in the neurons 
of the central nucleus of the amygdala, in the bed 
nucleus and in the nucleus accumbens shell reduces 
the reinforcing effects of narcogenic (amphetamine, 
fentanyl citrate, pentobarbital and leu-enkephalin), 
which indicates the importance of these structures 
of the extended amygdala in the regulation of the 
reinforcement system activated by the action of 
psycho-active substances (narcogenic).
3. The involvement of separate neurochemical 
mechanisms of the extended amygdala structures 
(dopamine, GABA and opioids), which realize 
the reinforcing effects of narcogenic, depends on 
their directed action on the processes of uncon-
ditioned reinforcement (self-stimulation of the 
brain), the acquisition and expression of condi-
tioned reinforcement (CPP). The reinforcing ef-
fects of various narcogenic drugs (psychomotor 
stimulants, opiate drugs, hypno-sedatives, and 
neuropeptides) have their own characteristics of 
involving the emotive and mnestic components of 
a common integrative reinforcement mechanism 
and are mediated by central stress mechanisms 
involving the receptors of CRF, dopamine and 
GABA, and, to a lesser extent, opioid receptors.
4. The blockade of CRF (astressin) receptors, the 
influx Na+ ionic currents (lidocaine) or D1 (SCH-
23390) and D2 dopamine receptors (sulpiride) in 
the extended amygdala reduces the self-stimu-
lation of the lateral hypothalamus. According to 
the degree of inhibition of self-stimulation, the 
substances can be arranged it in the following 
order: CRF antagonist (astressin)> lidocaine> 
sulpiride> SCH-23390 (substances are arranged 
in decreasing order of activity). A similar pat-
tern is also observed when astressin is admin-
istered into the nucleus accumbens shell, where 
the following pattern is observed in the degree 
of inhibition of self-stimulation: bicuculline> as-
tressin> sulpiride> SCH-23390 (the substances 
are also arranged in decreasing order of activity).
5. Elimination of the modulating effects of the ex-
tended amygdala on the hypothalamus blocks the 
reinforcing properties of opiates (fentanyl citrate) 
and opioids (leu-enkephalin), without affecting the 
psycho-activating effect of the psycho-motor stim-
ulant amphetamine and barbiturate pentobarbital. 
In the case of shifting the modulating effects from 
the nucleus accumbens shell to the hypothalamus 
(introduction of lidocaine, SCH-23390, astressin), 
the positive reinforcing effect of opiates (fentanyl 
citrate) is inverted into negative. None of the block-
ers, with the exception of astressin, significantly 
change the inhibitory effects of leu-enkephalin on 
hypothalamus self-stimulation, and astressin in the 
latter case aggravates the negative effect of leu-en-
kephalin on the self-stimulation reaction.
6. The blockade of GABAA receptors (bicucull-
ine), the influx Na+ ionic currents (lidocaine) or 
D1 (SCH-23390) dopamine receptors in the bed 
nucleus of the stria terminalis reduces, whereas 
the blockade of D2 dopamine receptors (sulpiride) 
moderately increases self-stimulation of the later-
al hypothalamus. According to the degree of inhi-
bition of self-stimulation, the substances can be 
arranged in the following order: lidocaine> SCH-
23390 ≈ bicuculline (the substances are arranged 
in decreasing order of activity).
7. The bed nucleus of the stria terminalis has a con-
trolling influence on the hypothalamus, which is 
predominantly of GABA- and dopaminergic na-
ture. GABA generates a negative (inhibitory) ac-
tion. Through D1 dopamine receptors a direct posi-
tive (activating) effect on the lateral hypothalamus 
Roik RO et al.: The value of  extended amygdala structures in emotive effects of...18
is realized, whereas D2 dopamine receptors of the 
bed nucleus limit the positive effects of narcogenic.
8. Functional shutdown of the nucleus accumbens 
shell with lidocaine prevents the acquisition of 
unconditioned (self-stimulation) and conditioned 
(place preference) reinforcing properties of narco-
genic: in the case of self-stimulation – all the studied 
narcogenic of stimulating and hypno-sedative pat-
terns, in the case of the acquisition of CPP – mainly 
opiates and opioids (fentanyl citrate, enkephalin), 
in the case of the expression of CPP – predominant-
ly psycho-motor stimulants (amphetamine).
9. The blockade of the D2 dopamine receptors of the 
nucleus accumbens with sulpiride prevents the man-
ifestation of the reinforcing properties (self-stimu-
lation, CPP) of predominantly stimulating narco-
genic (amphetamine). The D1 receptor blockade 
of the nucleus accumbens shell with SCH-23390 
prevents the manifestation of the reinforcing prop-
erties (self-stimulation, CPP) of mainly opiates and 
opioids (fentanyl citrate, leu-enkephalin).
10. The blockade of the GABAA receptors of the nu-
cleus accumbens shell with bicuculline prevents 
the manifestation of unconditioned reinforc-
ing properties (self-stimulation) of all the stud-
ied stimulating and hypno-sedative narcogenic 
(amphetamine, fentanyl citrate, pentobarbital, 
leu-enkephalin); At the same time, in relation to 
conditioned reinforcement (CPP), the GABAA 
receptor blockade is not always effective: it re-
duces the positive reinforcing effect of amphet-
amine and pentobarbital, without influencing the 
effects of opiates and opioids (fentanyl citrate 
and leu-enkephalin).
11. Consequently, the priority targets for influencing 
the reinforcing mechanisms of the brain in order 
to reduce the narcotic effect of the studied psycho-
tropic drugs are the CRF, dopamine and GABA 
receptors in the structures of the extended amyg-
dala, the selective blockade of which makes it 
possible to eliminate or significantly reduce the re-
inforcing effects of opiates (fentanyl citrate), opi-
oids (leu-enkephalin), psycho-motor stimulants 
(amphetamine) and barbiturates (pentobarbital).
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